Skip to main content
end|thewaitontario
HomeStart HereSee the DataPolicy & RightsResourcesYour RegionEducationNewsroomAbout
Take action
Start Here
Budget 2026: $965M budgeted, 67,509 children still waiting. Read our analysis →

New here? Start with our 2-minute guide to OAP registration — no sign-up required.

Preparing content
end|thewaitontario

Parent-led advocacy for Ontario families waiting for autism services.

Getting Started

  • Browse All Pages
  • Search
  • Diagnosis Guide
  • While You Wait
  • Facts (Citation Ready)

Common Questions

  • All Questions
  • How Long Is the Wait?
  • What Is the OAP?
  • How Many Are Waiting?
  • Options While Waiting
  • Funding Amounts

Tools

  • Next Steps Tool
  • Wait Estimator
  • Funding Estimator
  • Therapy Budget
  • Waitlist Tracker

Providers

  • Provider Directory
  • Choosing a Provider
  • Submit a Provider

Funding & Support

  • OAP Overview
  • Funding Guide
  • Eligibility
  • How to Register
  • DTC & RDSP

Your Region

  • Toronto
  • Ottawa
  • Hamilton
  • London
  • Mississauga
  • All Regions

Evidence & Data

  • Evidence Library
  • Data Hub
  • Waitlist Data
  • Cost Calculator
  • Data Stories
  • Where Does the Money Go?

Take Action

  • Action Hub
  • Write Your MPP
  • File Complaint
  • Advocacy Toolkit

About

  • Our Story
  • Transparency
  • Media References
  • Founder
  • Press
  • Contact
end|thewaitontario

Parent-led advocacy for Ontario families waiting for autism services.

Getting Started

  • Browse All Pages
  • Search
  • Diagnosis Guide
  • While You Wait
  • Facts (Citation Ready)

Common Questions

  • All Questions
  • How Long Is the Wait?
  • What Is the OAP?
  • How Many Are Waiting?
  • Options While Waiting
  • Funding Amounts

Tools

  • Next Steps Tool
  • Wait Estimator
  • Funding Estimator
  • Therapy Budget
  • Waitlist Tracker

Providers

  • Provider Directory
  • Choosing a Provider
  • Submit a Provider

Funding & Support

  • OAP Overview
  • Funding Guide
  • Eligibility
  • How to Register
  • DTC & RDSP

Your Region

  • Toronto
  • Ottawa
  • Hamilton
  • London
  • Mississauga
  • All Regions

Evidence & Data

  • Evidence Library
  • Data Hub
  • Waitlist Data
  • Cost Calculator
  • Data Stories
  • Where Does the Money Go?

Take Action

  • Action Hub
  • Write Your MPP
  • File Complaint
  • Advocacy Toolkit

About

  • Our Story
  • Transparency
  • Media References
  • Founder
  • Press
  • Contact
end|thewaitontario

Parent-led advocacy for Ontario families waiting for autism services.

  • Browse All Pages
  • Search
  • Diagnosis Guide
  • While You Wait
  • Facts (Citation Ready)
  • All Questions
  • How Long Is the Wait?
  • What Is the OAP?
  • How Many Are Waiting?
  • Options While Waiting
  • Funding Amounts
  • Next Steps Tool
  • Wait Estimator
  • Funding Estimator
  • Therapy Budget
  • Waitlist Tracker
  • Provider Directory
  • Choosing a Provider
  • Submit a Provider
  • OAP Overview
  • Funding Guide
  • Eligibility
  • How to Register
  • DTC & RDSP
  • Toronto
  • Ottawa
  • Hamilton
  • London
  • Mississauga
  • All Regions
  • Evidence Library
  • Data Hub
  • Waitlist Data
  • Cost Calculator
  • Data Stories
  • Where Does the Money Go?
  • Action Hub
  • Write Your MPP
  • File Complaint
  • Advocacy Toolkit
  • Our Story
  • Transparency
  • Media References
  • Founder
  • Press
  • Contact

Legal Disclaimer: This website presents advocacy arguments based on publicly available data and legal frameworks. While we strive for accuracy, this content is for informational purposes only and does not constitute legal or medical advice. Nothing on this website should be construed as a guarantee of any specific legal outcome.

Independence: End The Wait Ontario is a parent-led advocacy group. We are not affiliated with the Ontario government, the Ontario Autism Coalition, Autism Ontario, or the World Health Organization. We cite FOI data obtained by the Ontario Autism Coalition as a matter of public record. This does not constitute affiliation. References to these organizations are for informational purposes; no endorsement is implied.

Non-partisan policy advocacy: We advocate on policy outcomes for children and families and do not endorse any political party or candidate.

Statistics are current as of the dates cited and may change. For specific legal guidance, consult a licensed attorney. For medical advice, consult qualified healthcare professionals. Last updated: 2026.

Legal|Privacy|Terms|Cookies|Accessibility|Corrections|Authority

Advocacy, not anger. Data, not speculation.

Carroll v. Ontario · HRTO 2025-62264-I

© 2026 End The Wait Ontario. All rights reserved. · Parent-led advocacy · Not a government agency

Preparing content
  1. Home
  2. ›Autism Medication Ontario

What autism services are available in Ontario while waiting for OAP?

While waiting for OAP Core Clinical Services, families can access: Foundational Family Services (free, no waitlist), school-based IEP supports, Preschool Speech and Language programs, EarlyON Child and Family Centres, private therapy (if financially able), and DSO registration for transition planning.

Source: Ontario Autism Program

What free autism resources are available in Ontario?

Free autism resources in Ontario include: EarlyON Child and Family Centres (drop-in), Preschool Speech and Language (assessment/therapy), OAP Caregiver Workshops (training), and Foundational Family Services. These are available without the main OAP waitlist but do not replace intensive clinical therapy.

Source: Ontario.ca

What does the WHO say about early autism intervention timing?

The WHO Fact Sheet on Autism Spectrum Disorders (2023) states that timely access to early evidence-based psychosocial interventions can improve the ability of autistic children to communicate effectively and interact socially. Dawson et al. (2010, Pediatrics; PMID 19948568) confirmed in an RCT that ESDM (Early Start Denver Model) at 18–30 months produced significant developmental gains.

Source: WHO Fact Sheet: Autism Spectrum Disorders (2023); Dawson et al., Pediatrics 2010 (PMID 19948568)

Medication Guide

Autism Medication in Ontario

Medications do not treat autism itself — they treat co-occurring conditions such as anxiety, ADHD, irritability, sleep difficulties, and OCD that many autistic individuals experience. Understanding your options, coverage, and monitoring requirements helps families make informed decisions alongside their prescribers.

Quick Summary

  • Guide to medications commonly prescribed for autistic individuals in Ontario.
  • Coverage of risperidone, aripiprazole, ADHD medications, SSRIs, Ontario drug coverage, and working with prescribers.

Who this affects

These challenges are common among the children waiting for services.

Registered

88,17588,175

Children registered

Total in the Ontario Autism Program queue

CBC FOI Jan 2026

Funded

20,66620,666

Have active funding

Just 23.4% of registered children

CBC FOI Jan 2026

Waiting

67,50967,509

Still waiting

Registered. Diagnosed. Un-funded.

CBC FOI Jan 2026

Verified April 29, 2026 — CBC FOI Jan 2026

Share these numbers
Ontario Autism Program key statistics (CBC FOI Jan 2026, verified 2026-04-29)
MetricValue
Children registered88,175
Have active funding20,666
Still waiting67,509

Medication Use in Autism: Key Facts

Medication is one tool in a broader support plan. Understanding the landscape helps families ask informed questions of their medical team.

27–45%

of autistic individuals are prescribed at least one psychotropic medication (Jobski et al., 2017)

2

medications with Health Canada approval specifically for autism irritability: risperidone and aripiprazole

Free

most covered autism-related medications for Ontarians under 25 through OHIP+ with no other drug plan

70%+

of autistic individuals have at least one co-occurring mental health condition (Lai et al., 2019)

12–24 mo

typical wait for developmental pediatrics assessment in Ontario

~30%

of autistic individuals are prescribed more than one psychotropic medication simultaneously (polypharmacy)

What Medication Can and Cannot Do

Understanding the role of medication in autism care is essential before starting any prescription. Medication is most effective when combined with behavioural supports and therapy.

What Medication Can Help With

  • Reducing irritability, aggression, and self-injurious behaviours
  • Improving attention and reducing impulsivity (ADHD symptoms)
  • Reducing anxiety and panic responses
  • Improving sleep onset and duration
  • Reducing obsessive-compulsive symptoms
  • Stabilizing mood in co-occurring mood disorders
  • Creating a calmer baseline that makes therapy and learning more accessible

What Medication Cannot Do

  • Treat or cure autism itself — no such medication exists
  • Replace behavioural therapy, OT, speech therapy, or other supports
  • Improve social skills or communication directly
  • Eliminate sensory processing differences
  • Work as a long-term standalone solution without regular review
  • Be used safely without regular medical monitoring
  • Guarantee the same response in every individual — effects vary widely

Common Medications by Target Symptom

The following medications are commonly used in Ontario for autistic individuals. This is not a complete list. Prescribing decisions are individualized based on the person's specific symptoms, medical history, and other factors.

Irritability, Aggression & Self-Injury

Antipsychotics (Atypical)

The only medication class with Health Canada approval specifically for irritability associated with autism.

Risperidone (Risperdal)

  • Health Canada approved for irritability in autism (ages 5–16)
  • Reduces aggression, self-injury, and severe tantrums
  • Available as tablet, liquid, and orally dissolving tablet
  • Common side effects: weight gain, sedation, increased appetite
  • Requires metabolic monitoring (weight, glucose, lipids)
  • Covered on Ontario Drug Benefit (ODB) formulary

Aripiprazole (Abilify)

  • Health Canada approved for irritability in autism (ages 6–17)
  • Lower risk of metabolic side effects compared to risperidone
  • May cause restlessness (akathisia) in some individuals
  • Available as tablet and liquid formulation
  • Common side effects: weight gain, sedation, increased appetite
  • Covered on Ontario Drug Benefit (ODB) formulary
ADHD Symptoms: Attention, Impulsivity, Hyperactivity

ADHD Medications

ADHD co-occurs in approximately 50–70% of autistic individuals. Stimulants and non-stimulants are both used, though response rates may differ from non-autistic ADHD populations.

Methylphenidate (Ritalin, Biphentin, Concerta)

Stimulant
  • First-line for ADHD symptoms in many cases
  • Immediate and extended-release formulations available
  • Effects visible within 1–2 hours
  • Side effects: appetite suppression, sleep difficulties, irritability
  • Covered on ODB formulary

Guanfacine (Intuniv)

Non-Stimulant
  • Extended-release alpha-2 agonist
  • Useful when stimulants cause significant side effects
  • Can reduce both ADHD symptoms and irritability
  • Takes 4–8 weeks for full effect
  • Side effects: sedation, low blood pressure

Atomoxetine (Strattera)

Non-Stimulant
  • Non-controlled substance; preferred in some situations
  • Takes 4–8 weeks to reach full effect
  • Also has some antidepressant properties
  • Side effects: nausea, appetite changes, mood changes
  • Must be tapered when stopping
Anxiety, OCD & Depression

SSRIs and Anxiolytics

Anxiety disorders co-occur in approximately 40–50% of autistic individuals. Evidence for SSRIs is mixed in autism — they help some individuals significantly and are not effective for others.

SSRIs (Selective Serotonin Reuptake Inhibitors)

  • Fluoxetine (Prozac) — most studied SSRI in autism
  • Sertraline (Zoloft) — commonly prescribed for anxiety and OCD
  • Escitalopram (Cipralex) — well-tolerated, used for anxiety
  • Takes 4–8 weeks to reach therapeutic effect
  • Must be tapered slowly when discontinuing
  • Some autistic individuals experience increased agitation or activation at initiation — start low and go slow

Other Anxiolytics

  • Buspirone — non-habit-forming option for generalized anxiety
  • Clonidine — alpha-2 agonist; used for anxiety, sleep, and ADHD
  • Melatonin — widely used for sleep onset difficulties; available OTC
  • Hydroxyzine — antihistamine used short-term for acute anxiety
  • Benzodiazepines — generally avoided long-term due to tolerance and dependence risk
  • Propranolol — sometimes used for performance anxiety or activation

Monitoring and Safety

Safe medication use in autism requires regular monitoring. The Canadian Paediatric Society recommends specific assessments at initiation and ongoing intervals for antipsychotic and ADHD medications.

Antipsychotic Monitoring (Risperidone / Aripiprazole)

  • Baseline: Weight, BMI, waist circumference, fasting glucose, lipids, blood pressure, prolactin, movement assessment
  • 1 month: Weight, blood pressure, movement assessment
  • 3 months: Weight, BMI, blood pressure, fasting glucose, lipids, prolactin
  • Every 6–12 months: Full metabolic panel, movement assessment (AIMS), review of dose and continued need

Source: Canadian Paediatric Society — Antipsychotic Use in Children and Youth (2022)

ADHD Medication Monitoring

  • Baseline: Height, weight, heart rate, blood pressure, symptom rating scales
  • Each dose adjustment: Symptom response, side effects, height, weight, blood pressure
  • Every 6 months: Growth percentile tracking, blood pressure, symptom review
  • Annually: Comprehensive review — is medication still needed? Trial off medication if appropriate

Source: Canadian Paediatric Society — ADHD in Children and Youth (2018)

Ontario Drug Coverage Programs

Ontario has several programs that cover prescription medication costs. Eligibility depends on age, income, and existing drug benefit coverage.

OHIP+

Ontario Health Insurance Plan (Under 25)

Covers most prescription drugs on the Ontario Drug Benefit formulary at no cost for Ontarians under 25 who do not have another drug benefit plan.

  • No deductible or co-pay for eligible individuals
  • Must not have employer or private drug coverage
  • Covers most common autism-related medications
  • Prescription filled at any participating Ontario pharmacy
  • Your pharmacist verifies eligibility at point of sale
Learn More

ODB

Ontario Drug Benefit Program

Covers prescription drugs for eligible groups including Ontario Works recipients, Ontario Disability Support Program (ODSP) recipients, Trillium Drug Program registrants, and others.

  • Small co-pay ($2–$6.11 per prescription depending on eligibility category)
  • Covers drugs on the ODB formulary
  • Eligibility through ODSP, OW, or Trillium
  • Check the online formulary for specific medication coverage
  • Some medications require prior approval (Limited Use)
Learn More

Trillium

Trillium Drug Program

Helps Ontario residents of any age with high drug costs relative to their household income. An annual deductible (4% of net household income) is paid in quarterly installments.

  • No age limit — available to all Ontario residents
  • Deductible = 4% of net household income, paid quarterly
  • After deductible met, ODB covers the rest of the year
  • Apply through ServiceOntario or online at ontario.ca
  • Useful for families with significant ongoing medication costs
Learn More

Working with Your Prescriber

In Ontario, several types of medical professionals can prescribe medications for autism-related conditions. Building a collaborative relationship with your prescriber leads to better outcomes.

Types of Prescribers in Ontario

  • Developmental Pediatrician

    Most specialized for autism medication management. Conducts formal assessments and coordinates care. Wait time: 12–24+ months at most Ontario centres.

  • Child and Adolescent Psychiatrist

    Specializes in mental health co-occurring conditions. Can manage complex medication regimens and provide psychiatric assessment. Access through hospital outpatient or community programs.

  • Pediatrician

    Can manage first-line medications (ADHD medications, melatonin) and refer to specialists for complex needs. Most accessible.

  • Family Physician

    Can initiate and manage straightforward medications with specialist guidance. Comfort level with autism medications varies significantly.

Questions to Ask Your Prescriber

  • What condition are we targeting with this medication?
  • What is the expected timeline to see if it is working?
  • What are the most common side effects I should watch for?
  • What monitoring tests will be needed and how often?
  • What is the plan if this medication does not work or causes side effects?
  • Is this medication covered by OHIP+ or ODB?
  • How should we taper if we decide to stop?
  • How does this interact with any other medications my child takes?

Frequently Asked Questions

No. There is currently no medication that treats the core features of autism. Medications are prescribed to treat co-occurring conditions such as anxiety, ADHD, irritability, sleep difficulties, or obsessive-compulsive behaviours. Risperidone and aripiprazole are the only medications with Health Canada approval specifically for irritability associated with autism.
Coverage depends on the medication and your family's eligibility. OHIP+ covers most prescription medications at no cost for children and youth under 25 with no other drug benefit plan. The Ontario Drug Benefit (ODB) program covers eligible individuals including those on ODSP and Ontario Works. The Trillium Drug Program helps families with high drug costs relative to their income — an annual deductible of 4% of net household income applies. Check ontario.ca for the current formulary and program eligibility.
The most common side effects of risperidone in children include weight gain (often significant), increased appetite, sedation, elevated prolactin (which can affect growth and puberty), and metabolic changes. Regular monitoring of weight, BMI, fasting blood glucose, lipids, and prolactin levels is recommended by the Canadian Paediatric Society. Movement-related side effects (extrapyramidal symptoms) are possible and should be reported to your prescriber immediately.
Pediatricians, developmental pediatricians, child and adolescent psychiatrists, and family physicians can all prescribe medications for autism-related conditions in Ontario. Developmental pediatricians and child psychiatrists have the most specialized expertise. Wait times for developmental pediatrics are typically 12–24+ months in Ontario. Some families access psychiatry through hospital outpatient programs, school-based mental health services, or telehealth options.
Timeline varies by medication. Stimulant ADHD medications (methylphenidate) typically show effects within 1–2 hours and can be assessed within days. Non-stimulant ADHD medications (guanfacine, atomoxetine) take 4–8 weeks to reach full effect. SSRIs and antidepressants for anxiety typically take 4–8 weeks. Risperidone and aripiprazole for irritability may show initial effects within 1–2 weeks but full benefits often take 4–6 weeks. Always discuss timeline expectations with your prescriber before starting.

Find a Specialist and Access Support

Medication decisions work best alongside therapy and support. Our provider directory can help you find developmental pediatricians, psychiatrists, and other specialists across Ontario.

Find a Provider Near YouDaily Life with Autism Hub

Take Action

Help End the Wait

Your voice matters. Join thousands of Ontario families fighting for timely autism services.

Write to Your MPPShare Your Story

Verified References & Sources

Updated: Mar 2026

Government Reports & Data

[2020]
Autism ServicesVerified FAO Data
Financial Accountability Office of Ontario (FAO) • Report • 2020-07-21
View
[2024]
Ministry of Children, Community and Social Services: Spending Plan ReviewVerified FAO Data
Financial Accountability Office of Ontario (FAO) • Report • 2024-02-29
View
[2025]
Ontario Autism Coalition FOI update on Ontario Autism Program registrations and fundingVerified FAO Data
Ontario Autism Coalition • Report • 2025-12-10
View
[2024]
Diagnostic Hub Waitlist Data — FOI Response (Trillium Health Partners hospital system, not The Trillium newspaper)Verified FAO Data
Trillium Health Partners (hospital) • Report • 2024-03-15
View

Official Government Sources

[2025]
Canada Disability Benefit - How much you could receiveGovernment Source
Government of Canada • Government • 2025-06-20
View

Commitment to Accuracy: Our data is verified against official government reports (FAO, MCCSS), peer-reviewed scientific literature, and accessible public records. Last updated: March 24, 2026.

  • Ministry of Children, Community and Social Services: Spending Plan Review (2024). Financial Accountability Office of Ontario (2024)
  • Ontario Autism Coalition FOI update on Ontario Autism Program registrations and funding. Ontario Autism Coalition (December 2025)

Related Resources

  • Home
  • All Services
  • Diagnosis Hub
  • Financial Resources Hub
  • Education Hub
About This Article
Written by:Spencer Carroll - Founder & Autism AdvocateParent of autistic child navigating OAP system
Featured in CBC News Investigation
FOI Data Verified
Clip in WHO Social Media Reel
Active HRTO Advocacy
FAO & Legislative Assembly Cited

Where do you start?

Choose your path

The quickest routes to diagnosis guidance, evidence, practical support, and advocacy.

Just diagnosed?
First steps after an autism diagnosis
Already waiting?
What to do while on the waitlist
See the data
FOI-backed charts, methods, and evidence
Want change?
Write your MPP in 5 minutes

Verified Facts

Facts cited on this page

1 in 50 — According to the 2019 Canadian Health Survey on Children and Youth, about children and youth aged 1 to 17 in Canada had an autism diagnosis

Gov / Peer-ReviewedPublic Health Agency of Canada (2024)Verified: 2024-03-26

88,175 — children are registered in the Ontario Autism Program

SecondaryCBC FOI Jan 2026Verified: 2026-04-29

WHO recommends accessible, community-based early interventions for children with autism — timely evidence-based psychosocial interventions improve communication and social engagement

Gov / Peer-ReviewedWorld Health Organization (2023)Verified: 2023-11-15

23.4% — Only 20,666 children have active funding agreements () — less than one in four

SecondaryCBC FOI Jan 2026Verified: 2026-04-29
View our methodologyView all sourcesNext data update: 2026-05-15